Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) On May 14, 2009, Dr. Francois E. Nader accepted an offer to join the Board
of Directors of Noven Pharmaceuticals, Inc. (the "Company"), effective May 22,
2009, immediately following the Company's 2009 Annual Meeting of Stockholders
(the "Annual Meeting"). Because Dr. Nader was not identified as a director
nominee prior to the mailing of the Company's proxy materials for the Annual
Meeting, he is not among the individuals nominated for election at the Annual
Meeting. Accordingly, his appointment to the Company's Board of Directors will
become effective immediately after the Annual Meeting. Dr. Nader is also
expected to join the Audit Committee of the Company's Board of Directors at that
time.
Top of the Form
Add
NOVN to Portfolio
Set Alert
Email to a
Friend